Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Bezannes

7 clinical trials in Bezannes, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Bezannes at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Bezannes

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:FRUQUINTINIB
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Hidradenitis

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Bezannes

What the registry says about research in the country

01 Gastrointestinal Oncology

Research focusing on novel combination therapies for colorectal cancer and esophageal squamous cell carcinoma. Studies evaluate targeted treatments combining immunotherapy with conventional approaches.

  • Advanced Colorectal Adenocarcinoma Treatment
  • Locally Advanced Esophageal Cancer Management

Innovative approaches combining chemotherapy with targeted biological agents are being tested to improve patient outcomes.

02 Breast Cancer Research

Groundbreaking studies in early-stage breast cancer treatment, specifically focusing on hormone receptor-positive disease. Investigation of new endocrine therapy options for high-risk patients.

  • Node-Positive Breast Cancer
  • Hormone Receptor-Positive Disease

Clinical trials evaluating novel endocrine treatments to prevent cancer recurrence in high-risk populations.

03 Dermatological Conditions

Comprehensive research into the treatment of Hidradenitis Suppurativa, exploring both short-term and long-term therapeutic solutions with novel oral medications.

  • Moderate to Severe HS Management
  • Long-term Treatment Safety

Multiple trials examining the efficacy and safety profiles of new therapeutic agents for chronic skin conditions.

04 Head and Neck Oncology

Investigation of enhanced treatment protocols for head and neck squamous cell carcinoma, combining immunotherapy with standard radiation-chemotherapy approaches.

  • Post-surgical Treatment Optimization
  • Combined Modality Therapy

Studies focus on improving disease-free survival through innovative combination treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.